EV/Assets Ratio: 3.66x
Is the EV/Assets ratio high or low?
The EV/Assets ratio of 3.66x is 50% below its 5-year average of 7.37x, near the low end of its 5-year range (3.42x–11.30x).
As of Thursday, June 25, 2026. 38.04% below its 12-month average of 5.91x.
PODD EV/Assets Ratio Chart
PODD Average EV/Assets Ratio Chart
PODD Current vs Average EV/Assets Ratio Chart
PODD EV/Assets Ratio Metrics
EV/ASSETS RATIO
3.66x
EV/ASSETS RATIO AVG TTM
5.91x
EV/ASSETS RATIO AVG 3Y
5.95x
EV/ASSETS RATIO AVG 5Y
7.37x
EV/ASSETS RATIO AVG 10Y
7.80x
EV/ASSETS RATIO AVG 15Y
7.20x
EV/ASSETS RATIO AVG 20Y
6.30x
CURRENT VS TTM AVG
-38.04%
CURRENT VS 3Y AVG
-38.54%
CURRENT VS 5Y AVG
-50.35%
CURRENT VS 10Y AVG
-53.06%
CURRENT VS 15Y AVG
-49.18%
CURRENT VS 20Y AVG
-41.92%
PODD Competitors' EV/Assets Ratio
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Insulet Corp. (PODD) | $10.31B | 3.66x | 5.91x | 5.95x | 7.37x |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 0.56x | 0.52x | 0.58x | 0.69x |
| Baxter International Inc. (BAX)vs › | $10.87B | 0.93x | 0.90x | 1.04x | 1.31x |
| Charles River Laboratories International, Inc. (CRL)vs › | $9.73B | 1.65x | 1.51x | 1.59x | 1.94x |
| Henry Schein, Inc. (HSIC)vs › | $9.38B | 1.14x | 1.10x | 1.15x | 1.27x |
| Revvity, Inc. (RVTY)vs › | $11.78B | 1.19x | 1.11x | 1.18x | 1.38x |
| Align Technology, Inc. (ALGN)vs › | $12.24B | 1.79x | 1.75x | 2.53x | 3.71x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.57B | 0.86x | 0.88x | 0.89x | 0.99x |
| Oscar Health, Inc. (OSCR)vs › | $7.56B | 0.56x | 0.40x | 0.51x | 0.45x |
| Solventum Corporation (SOLV)vs › | $13.09B | 1.26x | 1.26x | 1.28x | 1.28x |
EV/Assets Ratio Formula & Definition
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
EV/Assets Ratio FAQ
- What is the EV/Assets ratio for Insulet Corp. (PODD)?
- The EV/Assets ratio for PODD stock is 3.66x.
- Is Insulet Corp.'s EV/Assets ratio high or low?
- The EV/Assets ratio of 3.66x is 50% below its 5-year average of 7.37x, near the low end of its 5-year range (3.42x–11.30x).
- What is the TTM average EV/Assets ratio for Insulet Corp. (PODD)?
- The TTM average EV/Assets ratio for PODD stock is 5.91x.
- What is the 3Y average EV/Assets ratio for Insulet Corp. (PODD)?
- The 3Y average EV/Assets ratio for PODD stock is 5.95x.
- What is the 5Y average EV/Assets ratio for Insulet Corp. (PODD)?
- The 5Y average EV/Assets ratio for PODD stock is 7.37x.
- What is the 10Y average EV/Assets ratio for Insulet Corp. (PODD)?
- The 10Y average EV/Assets ratio for PODD stock is 7.80x.
- What is the 15Y average EV/Assets ratio for Insulet Corp. (PODD)?
- The 15Y average EV/Assets ratio for PODD stock is 7.20x.
- What is the 20Y average EV/Assets ratio for Insulet Corp. (PODD)?
- The 20Y average EV/Assets ratio for PODD stock is 6.30x.
PODD EV/Assets Ratio History
| DATE | EV/ASSETS RATIO |
|---|---|
| 2026-06-24 | 3.66x |
| 2026-06-23 | 3.54x |
| 2026-06-22 | 3.42x |
| 2026-06-18 | 3.58x |
| 2026-06-17 | 3.53x |
| 2026-06-16 | 3.63x |
| 2026-06-15 | 3.64x |
| 2026-06-12 | 3.67x |
| 2026-06-11 | 3.66x |
| 2026-06-10 | 3.70x |
| 2026-06-09 | 3.91x |
| 2026-06-08 | 3.72x |
| 2026-06-05 | 3.76x |
| 2026-06-04 | 3.60x |
| 2026-06-03 | 3.52x |
| 2026-06-02 | 3.50x |
| 2026-06-01 | 3.64x |
| 2026-05-29 | 3.56x |
| 2026-05-28 | 3.51x |
| 2026-05-27 | 3.59x |
| 2026-05-26 | 3.77x |
| 2026-05-22 | 3.80x |
| 2026-05-21 | 3.84x |
| 2026-05-20 | 3.84x |
| 2026-05-19 | 3.79x |
| 2026-05-18 | 3.74x |
| 2026-05-15 | 3.62x |
| 2026-05-14 | 3.65x |
| 2026-05-13 | 3.65x |
| 2026-05-12 | 3.88x |
| 2026-05-11 | 3.78x |
| 2026-05-08 | 3.78x |
| 2026-05-07 | 3.93x |
| 2026-05-06 | 3.71x |
| 2026-05-05 | 3.82x |
| 2026-05-04 | 3.90x |
| 2026-05-01 | 3.98x |
| 2026-04-30 | 3.92x |
| 2026-04-29 | 3.65x |
| 2026-04-28 | 4.16x |
| 2026-04-27 | 4.28x |
| 2026-04-24 | 4.30x |
| 2026-04-23 | 4.36x |
| 2026-04-22 | 4.39x |
| 2026-04-21 | 4.36x |
| 2026-04-20 | 4.55x |
| 2026-04-17 | 4.62x |
| 2026-04-16 | 4.57x |
| 2026-04-15 | 4.59x |
| 2026-04-14 | 4.57x |
| 2026-04-13 | 4.49x |
| 2026-04-10 | 4.47x |
| 2026-04-09 | 4.52x |
| 2026-04-08 | 4.61x |
| 2026-04-07 | 4.59x |
| 2026-04-06 | 4.61x |
| 2026-04-02 | 4.63x |
| 2026-04-01 | 4.69x |
| 2026-03-31 | 4.75x |
| 2026-03-30 | 4.71x |
| 2026-03-27 | 4.72x |
| 2026-03-26 | 4.94x |
| 2026-03-25 | 4.89x |
| 2026-03-24 | 5.10x |
| 2026-03-23 | 5.13x |
| 2026-03-20 | 5.14x |
| 2026-03-19 | 5.17x |
| 2026-03-18 | 5.21x |
| 2026-03-17 | 5.21x |
| 2026-03-16 | 5.08x |
| 2026-03-13 | 4.97x |
| 2026-03-12 | 5.33x |
| 2026-03-11 | 5.39x |
| 2026-03-10 | 5.38x |
| 2026-03-09 | 5.43x |
| 2026-03-06 | 5.35x |
| 2026-03-05 | 5.44x |
| 2026-03-04 | 5.48x |
| 2026-03-03 | 5.46x |
| 2026-03-02 | 5.54x |
| 2026-02-27 | 5.57x |
| 2026-02-26 | 5.68x |
| 2026-02-25 | 5.60x |
| 2026-02-24 | 5.54x |
| 2026-02-23 | 5.63x |
| 2026-02-20 | 5.46x |
| 2026-02-19 | 5.62x |
| 2026-02-18 | 5.82x |
| 2026-02-17 | 5.84x |
| 2026-02-13 | 5.75x |
| 2026-02-12 | 5.71x |
| 2026-02-11 | 5.94x |
| 2026-02-10 | 5.98x |
| 2026-02-09 | 5.82x |
| 2026-02-06 | 5.73x |
| 2026-02-05 | 5.76x |
| 2026-02-04 | 5.95x |
| 2026-02-03 | 5.95x |
| 2026-02-02 | 6.08x |
| 2026-01-30 | 6.06x |
| 2026-01-29 | 6.04x |
| 2026-01-28 | 6.11x |
| 2026-01-27 | 6.27x |
| 2026-01-26 | 6.42x |
| 2026-01-23 | 6.43x |
| 2026-01-22 | 6.62x |
| 2026-01-21 | 6.74x |
| 2026-01-20 | 6.72x |
| 2026-01-16 | 6.80x |
| 2026-01-15 | 6.77x |
| 2026-01-14 | 6.69x |
| 2026-01-13 | 6.58x |
| 2026-01-12 | 6.59x |
| 2026-01-09 | 6.83x |
| 2026-01-08 | 6.92x |
| 2026-01-07 | 7.07x |
| 2026-01-06 | 6.96x |
| 2026-01-05 | 6.70x |
| 2026-01-02 | 6.69x |
| 2025-12-31 | 6.72x |
| 2025-12-30 | 6.79x |
| 2025-12-29 | 6.79x |
| 2025-12-26 | 6.82x |
| 2025-12-24 | 6.83x |
| 2025-12-23 | 6.75x |
| 2025-12-22 | 6.89x |
| 2025-12-19 | 6.85x |
| 2025-12-18 | 6.92x |
| 2025-12-17 | 6.84x |
| 2025-12-16 | 6.83x |
| 2025-12-15 | 6.89x |
| 2025-12-12 | 6.99x |
| 2025-12-11 | 6.95x |
| 2025-12-10 | 6.98x |
| 2025-12-09 | 6.95x |
| 2025-12-08 | 7.00x |
| 2025-12-05 | 7.19x |
| 2025-12-04 | 7.46x |
| 2025-12-03 | 7.26x |
| 2025-12-02 | 7.30x |
| 2025-12-01 | 7.34x |
| 2025-11-28 | 7.72x |
| 2025-11-26 | 7.71x |
| 2025-11-25 | 7.76x |
| 2025-11-24 | 7.96x |
| 2025-11-21 | 7.82x |
| 2025-11-20 | 7.39x |
| 2025-11-19 | 8.17x |
| 2025-11-18 | 7.87x |
| 2025-11-17 | 7.74x |
| 2025-11-14 | 7.85x |
| 2025-11-13 | 7.85x |
| 2025-11-12 | 7.95x |
| 2025-11-11 | 7.70x |
| 2025-11-10 | 7.56x |
| 2025-11-07 | 7.55x |
| 2025-11-06 | 7.63x |
| 2025-11-05 | 6.53x |
| 2025-11-04 | 6.64x |
| 2025-11-03 | 6.61x |
| 2025-10-31 | 6.50x |
| 2025-10-30 | 6.47x |
| 2025-10-29 | 6.56x |
| 2025-10-28 | 6.73x |
| 2025-10-27 | 6.76x |
| 2025-10-24 | 6.66x |
| 2025-10-23 | 6.71x |
| 2025-10-22 | 6.83x |
| 2025-10-21 | 6.82x |
| 2025-10-20 | 6.78x |
| 2025-10-17 | 6.61x |
| 2025-10-16 | 6.56x |
| 2025-10-15 | 6.48x |
| 2025-10-14 | 6.60x |
| 2025-10-13 | 6.53x |
| 2025-10-10 | 6.53x |
| 2025-10-09 | 6.65x |
| 2025-10-08 | 6.55x |
| 2025-10-07 | 6.50x |
| 2025-10-06 | 6.47x |
| 2025-10-03 | 6.42x |
| 2025-10-02 | 6.48x |
| 2025-10-01 | 6.35x |
| 2025-09-30 | 6.41x |
| 2025-09-29 | 6.45x |
| 2025-09-26 | 6.60x |
| 2025-09-25 | 6.71x |
| 2025-09-24 | 6.78x |
| 2025-09-23 | 6.80x |
| 2025-09-22 | 6.95x |
| 2025-09-19 | 6.86x |
| 2025-09-18 | 6.91x |
| 2025-09-17 | 6.68x |
| 2025-09-16 | 6.89x |
| 2025-09-15 | 7.05x |
| 2025-09-12 | 7.08x |
| 2025-09-11 | 7.00x |
| 2025-09-10 | 7.00x |
| 2025-09-09 | 7.31x |
| 2025-09-08 | 7.24x |
| 2025-09-05 | 7.22x |
| 2025-09-04 | 7.18x |
| 2025-09-03 | 7.12x |
| 2025-09-02 | 7.15x |
| 2025-08-29 | 7.04x |
| 2025-08-28 | 7.00x |
| 2025-08-27 | 6.93x |
| 2025-08-26 | 6.88x |
| 2025-08-25 | 6.82x |
| 2025-08-22 | 6.86x |
| 2025-08-21 | 6.80x |
| 2025-08-20 | 6.90x |
| 2025-08-19 | 6.79x |
| 2025-08-18 | 6.70x |
| 2025-08-15 | 6.66x |
| 2025-08-14 | 6.55x |
| 2025-08-13 | 6.41x |
| 2025-08-12 | 6.43x |
| 2025-08-11 | 6.33x |
| 2025-08-08 | 6.38x |
| 2025-08-07 | 6.30x |
| 2025-08-06 | 5.96x |
| 2025-08-05 | 6.04x |
| 2025-08-04 | 6.18x |
| 2025-08-01 | 6.12x |
| 2025-07-31 | 6.19x |
| 2025-07-30 | 6.40x |
| 2025-07-29 | 6.26x |
| 2025-07-28 | 6.28x |
| 2025-07-25 | 6.23x |
| 2025-07-24 | 6.16x |
| 2025-07-23 | 6.16x |
| 2025-07-22 | 6.13x |
| 2025-07-21 | 6.04x |
| 2025-07-18 | 6.11x |
| 2025-07-17 | 6.09x |
| 2025-07-16 | 6.19x |
| 2025-07-15 | 6.23x |
| 2025-07-14 | 6.27x |
| 2025-07-11 | 6.21x |
| 2025-07-10 | 6.38x |
| 2025-07-09 | 6.38x |
| 2025-07-08 | 6.36x |
| 2025-07-07 | 6.45x |
| 2025-07-03 | 6.46x |
| 2025-07-02 | 6.47x |
| 2025-07-01 | 6.44x |
| 2025-06-30 | 6.74x |
| 2025-06-27 | 6.71x |
| 2025-06-26 | 6.65x |
| 2025-06-25 | 6.57x |
| 2025-06-24 | 6.67x |
| 2025-06-23 | 6.60x |
| 2025-06-20 | 6.50x |
| 2025-06-18 | 6.48x |
| 2025-06-17 | 6.53x |
| 2025-06-16 | 6.58x |
| 2025-06-13 | 6.54x |
| 2025-06-12 | 6.51x |
| 2025-06-11 | 6.49x |
Showing the most recent 260 of 4,778 data points. The chart above shows the full history.
Related Metrics
About Insulet Corp.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ashley A. McEvoy